Report on a hepatitis C treatment successfully tested in Egypt costing under $300, a fraction of $80,000-plus standard pricing, expected within two years.
This item summarises coverage published by The Guardian.
Read the full article
ManufacturingPharco has switched on a new eye drops production line at its Amreya City site in Alexandria. Alongside it, the company is launching a broader push to get more people across Egypt and the region screened for eye disease before it does lasting damage.
CorporatePharco and Saudi German Health Egypt & North Africa signed a strategic memorandum of understanding on June 15, 2026, on the sidelines of Africa Health ExCon 2026 in Cairo. The agreement goes beyond a standard supply arrangement: it covers pharmaceutical supply chain logistics, ongoing training for medical professionals, scientific exchange, and joint sponsorship of healthcare initiatives and medical congresses.
CorporatePharco is building a pharmaceutical plant in Saudi Arabia, and Ashmore Investment Saudi Arabia is putting capital behind it. The deal, signed at the PIF Private Sector Forum, is the first investment under Ashmore's Industrial Initiative, and it hands Pharco's Saudi arm, Pharco KSA, fresh money to get the plant built.
For interview requests, image assets, or fact-checks, please contact our communications team directly.